Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
In Reply: Ms Dresser makes 2 important points, with which we concur completely. A limited supply of human donor oocytes provides yet another motivation, in addition to our stated ethical concerns, to pursue dedifferentiation of adult somatic cells. Additionally, we concur with her concerns regarding the use of the phrase "therapeutic cloning," both for the reason she gives and for the reason that we pointed out in our essay. Although there may ultimately be a therapeutic value obtained from the destruction of the embryo, the cloned embryo itself does not obtain any such therapeutic value. We might suggest alternative, more neutral modifiers such as stem cell, histogenic, or (more ambitiously) organogenic to describe this form of cloning.
Juengst E, Fossel M. Ethical Issues in Embryonic Stem Cell Research—Reply. JAMA. 2001;285(11):1439-1440. doi:10.1001/jama.285.11.1439